WOLVERINE ASSET MANAGEMENT LLC - NRX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,507
-50.2%
9,644
-7.3%
0.00%
Q2 2023$5,031
-31.5%
10,407
-6.6%
0.00%
Q1 2023$7,343
-58.2%
11,141
-29.6%
0.00%
Q4 2022$17,567
+3.3%
15,827
-34.8%
0.00%
Q3 2022$17,000
+6.2%
24,273
-13.4%
0.00%
Q2 2022$16,000
-81.0%
28,013
-18.5%
0.00%
-100.0%
Q1 2022$84,000
-52.5%
34,388
-7.3%
0.00%
-50.0%
Q4 2021$177,000
-55.1%
37,105
-12.8%
0.00%
-33.3%
Q3 2021$394,000
+74.3%
42,568
+118.4%
0.00%
+50.0%
Q2 2021$226,00019,4900.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 325,000$84,5000.06%
Texas Capital Bank Wealth Management Services Inc 63,290$16,4550.00%
XTX Topco Ltd 11,809$3,0700.00%
United Asset Strategies, Inc. 18,300$4,7580.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 160,700$41,7820.00%
UBS Group AG 1,210$3150.00%
NewEdge Advisors, LLC 7,125$1,8530.00%
Lido Advisors, LLC 13,000$3,3800.00%
OSAIC HOLDINGS, INC. 11,125$2,8910.00%
WELLS FARGO & COMPANY/MN 5,379$1,3990.00%
View complete list of NRX PHARMACEUTICALS INC shareholders